Status:
RECRUITING
Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution
Lead Sponsor:
Yandi Zhu
Conditions:
Ovarian Cancer
Radiotherapy Side Effect
Eligibility:
FEMALE
18+ years
Brief Summary
The goal of this observational study is to learn about in Patients treated with postoperative chemotherapy for ovarian tumors. The main questions it aims to answer are: • \[What symptom clusters are p...
Eligibility Criteria
Inclusion
- Pathologic diagnosis of ovarian cancer, the treatment plan adopts surgery combined with chemotherapy.
- Age ≥ 18 years old, know the real situation of the disease, the expected survival period \> 1 year.
- General condition is good, no history of psychiatric disease, no serious heart, brain, liver, kidney function abnormality.
- Informed consent and voluntarily participate in this study.
Exclusion
- those who have other tumors or whose diagnosis is unclear. those who cannot communicate properly, understand the questionnaire or complete the scale assessment.
- those who receive additional psychological interventions during the study period.
Key Trial Info
Start Date :
January 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06222008
Start Date
January 30 2022
End Date
June 30 2024
Last Update
January 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Hospital of Jiaxing
Jiaxing, China